Patients taking Kerendia saw significant reduction in cardiovascular death and hospitalization and urgent visits for heart ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF ...

The new Tempus software analyzes resting, non-ambulatory 12-lead ECG recordings to detect signs associated with having a low ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

Researchers at the German Center for Cardiovascular Research (DZHK) have identified a key molecule involved in a form of ...

Approval of Kerendia was based on results from the Phase III FINEARTS-HF trial, which demonstrated statistically significant ...

The US Food and Drug Administration has approved the use of finerenone (Kerendia) in heart failure (HF) patients with mildly ...

US FDA approves Bayer’s finerenone for new indication in patients with heart failure with left ventricular ejection fraction of ≥ 40%: Berlin Wednesday, July 16, 2025, 13:00 H ...

Part 1: Heart Failure: A Look at Low Ejection Fraction. Part 2: Exploring Heart Failure With Preserved Ejection Fraction. Part 3: Heart Failure With Reduced Ejection Fraction: Diagnosis and Evaluation ...

The signs and symptoms that bring a patient with heart failure with reduced ejection fraction (HFrEF) to the clinic for diagnosis are varied, and none incontrovertibly point to diagnosis.

Heart failure normal ejection fraction (HFNEF) is growing at an alarming rate and has a complex pathophysiology. The mortality and morbidity of HFNEF is comparable to heart failure with reduced ...

Understanding Ejection Fraction: In an interview with HT Lifestyle, Dr Rajiv Kovil, Diabetologist, Chairperson at Zandra Healthcare, Co-Founder of Rang De Neela initiative and Secretary at United ...